PTPI logo

PTPI
Petros Pharmaceuticals Inc

7,704
Mkt Cap
$247,878.00
Volume
107,948.00
52W High
$2.62
52W Low
$0.0017
PE Ratio
0.00
PTPI Fundamentals
Price
$0.0053
Prev Close
$0.0058
Open
$0.0058
50D MA
$0.0071
Beta
0.59
Avg. Volume
109,148.86
P/B
0.07
Loading...
Loading...

About

Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharma co-vigilance, market access relations, manufacturing, and distribution. It operates through the Prescription Medications and Medical Devices segments. The Prescription Medications segment handles Stendra, an FDA approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction, and H100, a topical formulation candidate for the treatment of acute Peyronie's disease. The Medical Devices segment consists of vacuum erection devices. The company was founded on May 14, 2020 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Petros Pharmaceuticals Inc?
What is the 52-week high for Petros Pharmaceuticals Inc?
What is the 52-week low for Petros Pharmaceuticals Inc?
What is Petros Pharmaceuticals Inc stock price today?
What was Petros Pharmaceuticals Inc stock price yesterday?
What is the Price-to-Book ratio of Petros Pharmaceuticals Inc?
What is the 50-day moving average of Petros Pharmaceuticals Inc?

Latest PTPI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.